bimatoprost
bimatoprost is a pharmaceutical drug with 19 clinical trials. Currently 1 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
8
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
1
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stop Retinal Ganglion Cell Dysfunction Study
Treatment of Hypopigmented Scars With Bimatoprost
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
Dose-Ranging Study of the Bimatoprost Ocular Insert
Clinical Trials (19)
Stop Retinal Ganglion Cell Dysfunction Study
Treatment of Hypopigmented Scars With Bimatoprost
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
Dose-Ranging Study of the Bimatoprost Ocular Insert
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19